Credit Suisse Maintains Neutral on Premier, Lowers Price Target to $35
Credit Suisse maintains Premier (NASDAQ:PINC) with a Neutral and lowers the price target from $37 to $35.
Benzinga · 1天前
Premier Inc. ProvideGx Program Partners With Somerset Pharma To Stabilize Pricing, Enhance Competition For Sulfamethoxazole/Trimethoprim
Benzinga · 08/04 12:05
Premier Inc. ProvideGx® Program Partners with Somerset Pharma to Stabilize Pricing, Enhance Competition for Sulfamethoxazole/Trimethoprim
Premier Inc., through its ProvideGx® program, has partnered with Somerset Pharma, LLC., to supply sulfamethoxazole/trimethoprim.
Business Wire · 08/04 12:00
Premier Healthcare Database Being Used by National Institutes of Health to Evaluate Impact of COVID-19 on Patients Across the U.S.
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced a data licensing agreement with the National Institutes of Health (NIH). Under the terms of the agreement, researchers in the Critical Care Medicine Department at the NIH Cl
Business Wire · 07/30 13:12
Premier Inc. Technology Predicts Number of COVID-19 Cases in U.S. Hospitals in Near Real Time
Premier Inc. has enhanced its crisis forecasting and planning technology to predict the COVID-19 census for any U.S. hospital on a given day.
Business Wire · 07/29 12:00
Kodak’s stock triples as company announces pandemic plan to start making pharmaceutical ingredients
marketwatch.com · 07/29 08:29
Premier, Inc. to Report Fiscal 2020 Fourth-Quarter and Full-Year Results and Host Conference Call on August 25, 2020
Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2020 fourth quarter and full year on Tuesday, August 25, 2020, at approximately 6:30 a.m. EDT. The company will also host a conference call at 8:00 a.m. EDT to d
Business Wire · 07/28 20:30
Premier Inc. Recommends FDA, DEA Reforms To Prevent Drug Shortages